| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
1999-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9cdc1e9f534270474deb25c282baba8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25573284d59bfe5e7b4e104ec329626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69ee99bcd958114df846b4e67ebb1139 |
| publicationDate |
2000-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1029929-A1 |
| titleOfInvention |
Method for determining the susceptibility of a NIDDM patient toward sulfonylurea therapy |
| abstract |
This invention concerns a method for determining thensusceptibility of a NIDDM patient toward sulfonylurea therapy comprising :n a) obtaining a sample from a NIDDM patient, said samplencomprising nucleic acid molecules containing the fragment of the SUR1 genencomprising the nucleotide in position -3 of intron 16, b) detecting the presence or the absence of the -3c allele innposition -3 of intron 16, nwhereby the presence of at least one -3c allele identifies a NIDDM patient withna higher susceptibility toward sulfonylurea therapy. |
| priorityDate |
1999-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |